May Hill Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
May Hill Capital's AMGN Position: Q1 2026 in Review
May Hill Capital increased its Amgen (AMGN) stake by 21% in Q1 2026, buying an estimated $69.9K and bringing the position to 1,119 shares worth $394K. The position accounts for 0.1% of the portfolio, ranked #137.
May Hill Capital first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $410K in Q1 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- May Hill Capital held 1,119 shares of Amgen worth $394K as of Q1 2026.
- May Hill Capital bought 196 Amgen shares in Q1 2026, an estimated $69.9K.
- Amgen made up 0.1% of May Hill Capital's portfolio in Q1 2026, its #137 holding.
- May Hill Capital first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
- May Hill Capital's Amgen position peaked at $410K in Q1 2025.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on May Hill Capital's 13F filing for Q1 2026, filed 6 May 2026.